skip to Main Content

Welcome

Celebrating 80 Years Of Service!

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."

ADVOCACY UPDATES

Changes To E/M Codes Beginning On January 1st

Effective January 1, 2021, the Centers for Medicare & Medicaid (CMS) finalized significant changes to…

read more

Additional COVID-19 Relief Up in the Air

House Speaker Nancy Pelosi (D-CA) and Treasury Secretary Steven Mnuchin appeared to be moving closer…

read more

CY 2021 Physician Fee Schedule Proposed Rule Summary

On August 3, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

04/01/21: Fellow Exam Application Deadline
Learn more

06/01/21: Research Grant Cycle
Learn more

06/26/21: Membership Application Deadline to be eligible for AAOA Member rate for the 2021 Basic Course

08/01/21:Scientific Abstract Submission Deadline
Learn More

09/01/21: Membership Application Deadline to be voted in at the 2021 Annual Meeting

12/01/21: Research Grant Cycle
Learn more

EDUCATION

Our 2021 AAOA Basic Course in Allergy & Immunology will be launched June 1st: Over 11 hrs of pre-learning, on-demand will set you up to gain the full value of our curriculum and engage in the live-stream session.

Live Stream July 8-11 will offer unique learning formats to offer learners the core concepts of allergy diagnosis and management. Join us and test your pre-work efforts for our Immunology & Pharmacotheapy Trivia Slams; Great Debates on Environmental Controls; Allergen Testing Panel “Bake Off,” Late Night with Dr. Levy, AAOA’s Escape Room Expedition, Hands On Testing and Dose Calculation Practica, Office Tours, and more.

Structured for otolaryngologists integrating more allergy assessment and management into their practice, AAOA members providing specialized allergy care who need to remain current with literature-based evidence and practice trends, residents, PA/NPs who work in otolaryngology, and allied health staff who support their physicians in the management of allergic patients. The Basic Course offers unique opportunities to learn the state of the art in allergy patient care. Learn More

IFAR

Available Now

IFAR Impact Factor: 2.454

aaoaf-ifar

IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More

Changes in Managing Practices

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2021 Basic Course in Allergy & Immunology
On-demand June 1; Live Stream July 8-11 | Virtual
Learn More and Register

USP 797 Online Module
Learn More and Register

2021 AAOA Annual Meeting
Pre-launch Mid-September
Live Stream Starting on Oct 16 | Virtual
Learn More

News and Updates

2021 AAOA Annual Meeting – Scientific Abstracts Submissions Now Open

Have novel research tied to allergy, inflammatory disease in ENT, comprehensive management of allergy and…

read more

Congress Sends Sesame Labeling Bill To President

By Beth Wang / April 15, 2021 at 11:57 AM The House on Wednesday (April 14) passed…

read more
College Allergy Symptoms Treatment Back to Shcool

PRACTICE RESOURCES

AAOA Practice Resource Tool Kit

The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.

Read More

PATIENT CORNER

Health Policy Updates tied to COVID-19

HILL UPDATES

  • Senate Republicans released an updated version of the CARES Act on Sunday, March 22nd.  The amended package is estimated at $1.8 trillion, with the text available here. The funding provisions are included in Division B, which is available here. The updated summary from Senate Republicans is here.  
    • After two failed procedural votes on Sunday evening and Monday afternoon, negotiations continued through Monday on a bill that could gain the 60 votes needed to pass the procedural hurdle. Majority Leader McConnell said that a vote may not occur until Friday or Saturday.
  • On the other side of the Capitol, Speaker Pelosi released a separate version of the phase 3 stimulus package in the House earlier on Monday, the Take Responsibility for Workers and Families Act.  The bill provides additional appropriations funding for each of the 12 appropriations bills, including Labor, Health and Human Services appropriations.  The bill also includes provisions related to paid sick leave, protecting the health care workforce and related economic provisions.  We are providing summaries of a few key health care items below, and we will send a link to the updated bill text when we receive it.
    • Coverage of Testing and Treatment: the bill would extend coverage of COVID-19 testing and treatment for Medicaid, Medicare and private health insurance plans. It also provides optional coverage for uninsured individuals under Medicaid.
    • Other Health Care Provisions:
      • Extends funding for Community Health Centers, the National Health Service Corps, Teaching Centers that Operate GME Programs, the Special Diabetes Program and the Special Diabetes Program for Indians through November 30, 2020. This is a change from the Senate version that provided for a two-year extension.
      • Requires Part D plans to allow beneficiaries to obtain up to three-month supply of their Part D prescription drugs during the COVID-19 public health emergency. 
      • Clarifies coverage requirements for in vitro diagnostic tests in compliance with the Food and Drug Administration’s (FDA) guidance on diagnostic tests for COVID-19 during a public health emergency.
      • Includes a Sense of Congress that during the COVID-19 pandemic health care providers should refrain from balance billing consumers for out-of-network claims related to COVID-19 testing or treatment, and insurance companies should do their utmost to secure access to in-network treatment for their plan participants.
      • Allows for the National Disaster Medical System to reimburse for the cost of COVID-19 treatment expenses.
      • Provides additional support for public health data and surveillance systems, as well as the public health workforce.
      • Establishes a loan program to help eligible health care organizations with anticipated revenue loss or higher operating costs as a result of COVID-19. 
  • Today Senators Chris Murphy (D-CT) and Brian Schatz (D-HI) introduced the “Medical Supply Chain Emergency Act” that would force implementation of the Defense Production Act (DPA) of 1950. The bill would require the President to use authorities under the DPA to require emergency production of medical equipment to address the COVID-19 outbreak. Learn more here.  A House companion bill is expected to be introduced in the coming days.

ADMINISTRATION UPDATES

  • CMS released COVID-19 checklists and toolkits for state Medicaid and CHIP programs to help speed states’ access to emergency flexibilities and resources. A link to these resources can be found here: https://www.cms.gov/newsroom/press-releases/trump-administration-releases-covid-19-checklists-and-tools-accelerate-relief-state-medicaid-chip.
  • On March 22nd, CMS announced it is granting exceptions from reporting requirements and extensions for clinicians participating in Medicare quality reporting programs for upcoming measure reporting and data submission.  More details can be found here: https://www.cms.gov/newsroom/press-releases/cms-announces-relief-clinicians-providers-hospitals-and-facilities-participating-quality-reporting.
    • Provider Programs:
      • ESRD Quality Incentive Program: 2019 Q4 data submission is optional. CMS will not count data from January 1, 2020 through June 30, 2020.
      • Quality Payment Program and the Medicare Shared Savings Program: 2019 data submission deadline is extended by a month until April 30, 2020. Providers who don’t report by April 30 will qualify for the automatic extreme and uncontrollable circumstances policy and will receive a neutral payment adjustment for the 2021 MIPS payment year.  Options for the 2020 performance year are still being evaluated.
    • Hospital Programs:
      • ASC Quality Reporting Program: deadlines for October 1, 2019 to December 1, 2019 (Q4) data submission is optional. Data does not need to be submitted for January 1, 2020 to June 30, 2020.
Back To Top